Elecsys Phospho-Tau (181P) CSF
Classification
- Category
- Immunoassay & Serology
- Technology
- Chemiluminescence Immunoassay
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
Intended use Elecsys β-Amyloid (1-42) CSF II and Elecsys Phospho‑Tau (181P) CSF are in vitro electrochemiluminescence immunoassays for the measurement of the β‑Amyloid (1‑42) (Abeta42) and Phospho‑Tau (181P) (pTau181) protein concentrations in cerebrospinal fluid (CSF) from adult patients aged 55 years and older being evaluated for Alzheimer's disease (AD) and other causes of cognitive impairment…
The safety and effectiveness of the Elecsys Phospho-Tau (181P) CSF assay have not been established for monitoring responses to therapies.The electrochemiluminescence immunoassay “ECLIA” is intended fo
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-06
2026-10-17
availability varies